Protease inhibitors:: Synthesis of potent bacterial collagenase and matrix metalloproteinase inhibitors incorporating N-4-nitrobenzylsulfonylglycine hydroxamate moieties

被引:61
作者
Scozzafava, A [1 ]
Supuran, CT [1 ]
机构
[1] Univ Florence, Lab Chim Inorgan & Bioinorgan, I-50121 Florence, Italy
关键词
D O I
10.1021/jm990594k
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
A series of compounds was prepared by reaction of alkyl/arylsulfonyl halides with N-4-nitrobenzylglycine, followed by conversion of the COOK to the CONHOH group, with hydroxylamine in the presence of carbodiimides. Other structurally related compounds were obtained by reaction of N-4-nitrobenzylglycine with aryl isocyanates, arylsulfonyl isocyanates, or benzo;yl isothiocyanate, followed by the similar conversion of the COOK into the CONHOH moiety. Another subseries of derivatives was prepared from sulfanilyl- or metanilyl-4-nitrobenzylglycine by reaction with arylsulfonyl isocyanates, followed by conversion of the COOK to the hydroxamate moiety. The new compounds were assayed as inhibitors of four matrix metalloproteinases (MMPs), MMP-1, MMP-2, MMP-8, and MMP-9, and of the Clostridium histolyticum collagenase (ChC). Some of the prepared hydroxamate derivatives proved to be very effective collagenase/gelatinase inhibitors, depending on the substitution pattern at the sulfonamido moiety. Substitutions leading to best inhibitors of MMP-1, a short pocket enzyme, were those involving pentafluorophenylsulfonyl or 3-trifluoromethylphenylsulfonyl moieties at P-1, (K-I's of 3-5 nM). For MMP-2, MMP-8, and MMP-9 (deep-pocket enzymes), best inhibitors were especially those containing long perfluoroalkylsulfonyl and substituted-arylsulfonyl moieties, such as pentafluorophenylsulfonyl, 3- and 4-protected-aminophenylsulfonyl, 3- and 4-carboxyphenylsulfonyl, arylsulfonylureido, or arylsulfonylureidosulfanilyl/metanilyl moieties, at P-1. Bulkier groups in this position, such as 1- and 2-naphthyl, substituted-naphthyl, or quinolin-8-yl moieties among others, led to less effective MMP/ChC inhibitors. Best ChC inhibitors were again those containing pentafluorophenylsulfonyl or 3- and 4-protected-aminophenylsulfonyl P-1 anchoring groups, suggesting that this protease is also a short-pocket wider-neck one (more similar to MMP-1). This study also proves that the 4-nitrobenzyl moiety is an efficient Pz anchoring moiety and that sulfonylureido, ureido, or carboxythioureido substitutions at P-1 are also tolerated for obtaining potent sulfonylated amino acid hydroxamate-like MMP/ChC inhibitors.
引用
收藏
页码:1858 / 1865
页数:8
相关论文
共 47 条
[1]   Design, synthesis, and biological evaluation of potent thiazine- and thiazepine-based matrix metalloproteinase inhibitors [J].
Almstead, NG ;
Bradley, RS ;
Pikul, S ;
De, B ;
Natchus, MG ;
Taiwo, YO ;
Gu, F ;
Williams, LE ;
Hynd, BA ;
Janusz, MJ ;
Dunaway, CM ;
Mieling, GE .
JOURNAL OF MEDICINAL CHEMISTRY, 1999, 42 (22) :4547-4562
[2]   Molecular recognition of protein-ligand complexes: Applications to drug design [J].
Babine, RE ;
Bender, SL .
CHEMICAL REVIEWS, 1997, 97 (05) :1359-1472
[3]  
BIETH JG, 1995, METHOD ENZYMOL, V248, P59
[4]   Insights into MMP-TIMP interactions [J].
Bode, W ;
Fernandez-Catalan, C ;
Grams, F ;
Gomis-Rüth, FX ;
Nagase, H ;
Tschesche, H ;
Maskos, K .
INHIBITION OF MATRIX METALLOPROTEINASES: THERAPEUTIC APPLICATIONS, 1999, 878 :73-91
[5]  
BOND MD, 1984, BIOCHEMISTRY-US, V23, P3077, DOI 10.1021/bi00308a035
[6]   CHARACTERIZATION OF THE INDIVIDUAL COLLAGENASES FROM CLOSTRIDIUM-HISTOLYTICUM [J].
BOND, MD ;
VANWART, HE .
BIOCHEMISTRY, 1984, 23 (13) :3085-3091
[7]   Carbonic anhydrase inhibitors: Synthesis of water-soluble, topically effective intraocular pressure lowering aromatic/heterocyclic sulfonamides containing 8-quinoline-sulfonyl moieties: Is the tail more important than the ring? [J].
Borras, J ;
Scozzafava, A ;
Menabuoni, L ;
Mincione, F ;
Briganti, F ;
Mincione, G ;
Supuran, CT .
BIOORGANIC & MEDICINAL CHEMISTRY, 1999, 7 (11) :2397-2406
[8]   Matrix metalloproteinase inhibitors in arthritis [J].
Bottomley, KM ;
Johnson, WH ;
Walter, DS .
JOURNAL OF ENZYME INHIBITION, 1998, 13 (02) :79-101
[9]   Design, synthesis, and biological evaluation of matrix metalloproteinase inhibitors derived from a modified proline scaffold [J].
Cheng, MY ;
De, B ;
Almstead, NG ;
Pikul, S ;
Dowty, ME ;
Dietsch, CR ;
Dunaway, CM ;
Gu, F ;
Hsieh, LC ;
Janusz, MJ ;
Taiwo, YO ;
Natchus, MG ;
Hudlicky, T ;
Mandel, M .
JOURNAL OF MEDICINAL CHEMISTRY, 1999, 42 (26) :5426-5436
[10]  
DIOSZEGI M, 1995, METHOD ENZYMOL, V248, P413